India's Pharmaceutical Exports

Country Profile

Chad

Chad is an emerging destination for Indian pharmaceutical exports — $45.7M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $10.6M. The compound annual growth rate since FY2015 stands at 12.0%.

🇹🇩 $45.7M · 3.5× growth since FY2015 · 12.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$45.7M
Exports FY2025–26 DGCIS
3.5×
Growth FY2015→2026
12.0%
CAGR FY2015→2026
76%
Medicines Share
4
Product Categories Supplied
Chad is an emerging destination for Indian pharmaceutical exports — $45.7M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $10.6M. The compound annual growth rate since FY2015 stands at 12.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $34.7M (75.9%) Vaccines $10.6M (23.1%) Surgical & Hospital Supplies $435K (1.0%) Medicine Ingredients $12K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Chad in the RBI overseas direct investment dataset (2011–2026).